# Dex as Analgesic Adjuvant in OSA Patients

> **NCT03613558** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Montefiore Medical Center**

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03613558
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to recruit patients because the surgeon left the hospital
- **Last updated:** 2018-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03613558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03613558, "Dex as Analgesic Adjuvant in OSA Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03613558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*